Breckenridge Sues KV In Vitamin Patent Dispute

Law360, New York (September 2, 2008, 12:00 AM EDT) -- Breckenridge Pharmaceutical Inc. has filed a declaratory judgment action seeking to invalidate a patent for a KV Pharmaceutical Co. vitamin supplement in an ongoing infringement dispute between the two companies.

In a complaint filed Monday in the U.S. District Court for the Southern District of Florida, Breckenridge also asked a judge to declare that its new vitamin supplement for people with anemia, Ferrex, does not infringe the patent.

In addition to KV, the suit names KV subsidiary Ther-Rx and Albion International Inc., which owns the patent-at-issue,...
To view the full article, register now.